CG
ASXC

Cutler Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Cutler Group’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,258
Closed -$12K – 4920
2022
Q4 		$12K Sell
36,258
-2,802
-7% -$1.14K ﹤0.01% 2602
2022
Q3 		$17K Sell
39,060
-3,098
-7% -$1.61K ﹤0.01% 2743
2022
Q2 		$16K Hold
42,158
– – ﹤0.01% 2878
2022
Q1 		$26K Sell
42,158
-18,600
-31% -$14.3K ﹤0.01% 2834
2021
Q4 		$67K Sell
60,758
-1,300
-2% -$2.01K ﹤0.01% 2172
2021
Q3 		$114K Buy
62,058
+24,414
+65% +$54.8K 0.01% 1814
2021
Q2 		$119K Buy
37,644
+19,734
+110% +$49.3K 0.01% 1724
2021
Q1 		$58K Buy
+17,910
New +$64.9K ﹤0.01% 2241
2019
Q4 		– Sell
-213
Closed -$740 – 4764
2019
Q3 		$1K Buy
213
+16
+8% +$218 ﹤0.01% 3890
2019
Q2 		$3K Buy
+197
New +$4.31K ﹤0.01% 3446
2019
Q1 		– Sell
-231
Closed -$7.74K – 4913
2018
Q4 		$6K Sell
231
-200
-46% -$9.09K ﹤0.01% 2869
2018
Q3 		$32K Sell
431
-155
-26% -$10.5K ﹤0.01% 1920
2018
Q2 		$33K Buy
586
+494
+537% +$18K ﹤0.01% 1868
2018
Q1 		$2K Hold
92
– – ﹤0.01% 3882
2017
Q4 		$2K Sell
92
-370
-80% -$11.4K ﹤0.01% 4254
2017
Q3 		$8K Sell
462
-53
-10% -$617 ﹤0.01% 4032
2017
Q2 		$4K Hold
515
– – ﹤0.01% 5112
2017
Q1 		$8K Sell
515
-177
-26% -$3.07K ﹤0.01% 4318
2016
Q4 		$11K Buy
692
+123
+22% +$2.52K ﹤0.01% 4136
2016
Q3 		$12K Sell
569
-62
-10% -$1.13K ﹤0.01% 4037
2016
Q2 		$10K Sell
631
-941
-60% -$29.5K ﹤0.01% 4187
2016
Q1 		$86K Buy
1,572
+1,510
+2,435% +$64.7K 0.01% 1752
2015
Q4 		$1K Buy
+62
New +$2K ﹤0.01% 6148

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's ASXC Position: Q1 2023 in Review

Cutler Group sold out of Asensus Surgical, Inc. (ASXC) in Q1 2023, closing a stake of 36,258 shares — an estimated $12K sold.

Cutler Group first reported a position in ASXC in Q4 2015 and held it in 23 quarters. The position peaked at $119K in Q2 2021. 79 funds tracked by Wall St. Rank hold ASXC as of Q1 2023.

  • Cutler Group reported no remaining Asensus Surgical, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 36,258 Asensus Surgical, Inc. shares in Q1 2023, an estimated $12K.
  • Cutler Group first reported a position in Asensus Surgical, Inc. in Q4 2015 and held it in 23 quarters.
  • Cutler Group's Asensus Surgical, Inc. position peaked at $119K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.